Chargement en cours...
Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
The apparently near-term effects of the monoclonal antibody BAN2401 in slowing the progression of prodromal Alzheimer's disease (AD) has created cautious optimism about the therapeutic use of antibodies that neutralize cytotoxic soluble amyloid-β aggregates, rather than removing plaque. Plaque...
Enregistré dans:
| Publié dans: | Research (Wash D C) |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AAAS
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750119/ https://ncbi.nlm.nih.gov/pubmed/31549066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34133/2019/5341375 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|